DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Thymosin beta-4 is an investigational drug.
There have been 9 clinical trials for Thymosin beta-4. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Keratoconjunctivitis Sicca, Myocardial Infarction, and Dry Eye Syndromes. The leading clinical trial sponsors are RegeneRx Biopharmaceuticals, Inc., sigma-tau i.f.r. S.p.A., and ReGenTree, LLC.
Recent Clinical Trials for Thymosin beta-4
|A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction||RegeneRx Biopharmaceuticals, Inc.||Phase 2|
|Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye||ORA, Inc.||Phase 2|
|Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye||ReGenTree, LLC||Phase 2|